PGNX / Progenics Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Progenics Pharmaceuticals, Inc.
US ˙ NASDAQ ˙ US7431871067
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

Insideraktier19.054.832 shares
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

N/A

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

N/A

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Progenics Pharmaceuticals, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i PGNX / Progenics Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2019-09-09 LTE Partners, LLC 21.480 4,9393 21.480 4,9393 106.096 60
2019-09-09 Velan Capital, L.P. 72.023 4,9947 72.023 4,9947 359.733
2019-09-05 LTE Partners, LLC 43.520 4,6208 43.520 4,6208 201.097
2019-09-04 Velan Capital, L.P. 243.614 4,5093 243.614 4,5093 1.098.529
2019-09-03 Velan Capital, L.P. 277.424 4,3937 277.424 4,3937 1.218.918
2019-08-26 Velan Capital, L.P. 73.230 4,3003 73.230 4,3003 314.911
2019-08-23 Velan Capital, L.P. 130.826 4,3087 130.826 4,3087 563.690
2014-07-21 Broadfin Healthcare Master Fund Ltd 388.659 4,7300 388.659 4,7300 1.838.357
2014-07-18 Broadfin Healthcare Master Fund Ltd 388.200 4,7300 388.200 4,7300 1.836.186

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PGNX / Progenics Pharmaceuticals, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i PGNX / Progenics Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2017-02-15 Broadfin Healthcare Master Fund Ltd 150.000 9,5500 150.000 9,5500 1.432.500 355
2017-02-14 Broadfin Healthcare Master Fund Ltd 150.000 9,6800 150.000 9,6800 1.452.000
2017-02-14 Broadfin Healthcare Master Fund Ltd 100.000 9,7000 100.000 9,7000 970.000
2017-02-14 Broadfin Healthcare Master Fund Ltd 50.000 9,7000 50.000 9,7000 485.000
2017-02-14 Broadfin Healthcare Master Fund Ltd 52.600 9,7000 52.600 9,7000 510.220
2017-02-13 Broadfin Healthcare Master Fund Ltd 100.000 9,7000 100.000 9,7000 970.000
2017-02-09 Broadfin Healthcare Master Fund Ltd 100.000 9,6600 100.000 9,6600 966.000
2017-02-09 Broadfin Healthcare Master Fund Ltd 100.000 9,7500 100.000 9,7500 975.000
2017-02-09 Broadfin Healthcare Master Fund Ltd 1.300 9,6850 1.300 9,6850 12.590

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

PGNX / Progenics Pharmaceuticals, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2020-06-23 2020-06-19 4 Maeusli Heinz Christoph PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 -16.393 0
2020-06-23 2020-06-19 4 Maeusli Heinz Christoph PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 -40.000 0
2020-06-23 2020-06-19 4 MacDougall Ann L. PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 -36.065 0
2020-06-23 2020-06-19 4 MacDougall Ann L. PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 -40.000 0
2020-06-23 2020-06-19 4 Ferrante Karen Jean PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,74 -25.000 0
2020-06-23 2020-06-19 4 Ferrante Karen Jean PGNX Stock Option (Right to Buy) D - Sale to Issuer D 8,99 -25.000 0
2020-06-23 2020-06-19 4 Ferrante Karen Jean PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,47 -20.000 0
2020-06-23 2020-06-19 4 Ferrante Karen Jean PGNX Stock Option (Right to Buy) D - Sale to Issuer D 6,95 -20.000 0
2020-06-23 2020-06-19 4 Ferrante Karen Jean PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,89 -20.000 0
2020-06-23 2020-06-19 4 Ferrante Karen Jean PGNX Stock Option (Right to Buy) D - Sale to Issuer D 6,72 -20.000 0
2020-06-23 2020-06-19 4 Ferrante Karen Jean PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,50 -40.000 0
2020-06-23 2020-06-19 4 Ende Eric J PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 -16.393 0
2020-06-23 2020-06-19 4 Ende Eric J PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 -40.000 0
2020-06-23 2020-06-19 4 Campbell Bradley L PGNX Stock Option (Right to Buy) D - Sale to Issuer D 8,99 -25.000 0
2020-06-23 2020-06-19 4 Campbell Bradley L PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,74 -25.000 0
2020-06-23 2020-06-19 4 Campbell Bradley L PGNX Stock Option (Right to Buy) D - Sale to Issuer D 6,95 -20.000 0
2020-06-23 2020-06-19 4 Campbell Bradley L PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,89 -28.000 0
2020-06-23 2020-06-19 4 Campbell Bradley L PGNX Common Stock D - Sale to Issuer D -12.000 0
2020-06-23 2020-06-19 4 Ber Gerard PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 -16.393 0
2020-06-23 2020-06-19 4 Ber Gerard PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 -40.000 0
2020-06-23 2020-06-19 4 Ber Gerard PGNX Common Stock D - Sale to Issuer D -50.000 0
2020-06-23 2020-06-19 4 Mims David W. PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 -16.393 0
2020-06-23 2020-06-19 4 Mims David W. PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,01 -40.000 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,77 -82.214 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,52 -90.750 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 6,62 -94.875 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,52 -82.500 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 11,32 -82.500 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 6,65 -66.000 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,70 -75.000 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,70 -52.800 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,03 -48.000 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 9,81 -40.000 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 7,40 -60.000 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,83 -25.000 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Stock Option (Right to Buy) D - Sale to Issuer D 5,35 -6.000 0
2020-06-23 2020-06-19 4 Wong Vivien PGNX Common Stock D - Sale to Issuer D -4.121 0
2020-06-23 2020-06-19 4 Tenbarge Bryce PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,77 -82.214 0
2020-06-23 2020-06-19 4 Tenbarge Bryce PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,52 -90.750 0
2020-06-23 2020-06-19 4 Tenbarge Bryce PGNX Stock Option (Right to Buy) D - Sale to Issuer D 6,62 -75.900 0
2020-06-23 2020-06-19 4 Tenbarge Bryce PGNX Stock Option (Right to Buy) D - Sale to Issuer D 11,32 -66.000 0
2020-06-23 2020-06-19 4 Tenbarge Bryce PGNX Stock Option (Right to Buy) D - Sale to Issuer D 6,77 -75.000 0
2020-06-23 2020-06-19 4 Osorio Benedict PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,77 -82.214 0
2020-06-23 2020-06-19 4 Osorio Benedict PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,52 -90.750 0
2020-06-23 2020-06-19 4 Osorio Benedict PGNX Stock Option (Right to Buy) D - Sale to Issuer D 6,62 -100.000 0
2020-06-23 2020-06-19 4 Osorio Benedict PGNX Common Stock D - Sale to Issuer D -21.202 0
2020-06-23 2020-06-19 4 Das Asha PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,77 -82.214 0
2020-06-23 2020-06-19 4 Das Asha PGNX Stock Option (Right to Buy) D - Sale to Issuer D 4,56 -125.000 0
2020-03-04 2020-03-02 4 Fabbio Patrick PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,77 82.214 82.214
2020-03-04 2020-03-02 4 Tenbarge Bryce PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,77 82.214 82.214
2020-03-04 2020-03-02 4 Wong Vivien PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,77 82.214 82.214
2020-03-04 2020-03-02 4 Osorio Benedict PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,77 82.214 82.214
2020-03-04 2020-03-02 4 Das Asha PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,77 82.214 82.214
2019-12-17 2019-12-13 4 Ber Gerard PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 40.000 40.000
2019-12-17 2019-12-13 4 Ber Gerard PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 16.393 16.393
2019-12-17 2019-12-13 4 Ende Eric J PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 40.000 40.000
2019-12-17 2019-12-13 4 Ende Eric J PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 16.393 16.393
2019-12-17 2019-12-13 4 MacDougall Ann L. PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 40.000 40.000
2019-12-17 2019-12-13 4 MacDougall Ann L. PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 36.065 36.065
2019-12-17 2019-12-13 4 Mims David W. PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 40.000 40.000
2019-12-17 2019-12-13 4 Mims David W. PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 16.393 16.393
2019-12-17 2019-12-13 4 Maeusli Heinz Christoph PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 40.000 40.000
2019-12-17 2019-12-13 4 Maeusli Heinz Christoph PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,01 16.393 16.393
2019-09-27 3 Ber Gerard PGNX Common Stock, $0.0013 par value D 100.000
2019-09-27 3 Ber Gerard PGNX Common Stock, $0.0013 par value D 100.000
2019-09-27 3 Ber Gerard PGNX Common Stock, $0.0013 par value D 100.000
2019-09-27 3 Ende Eric J PGNX Common Stock, $0.0013 par value D 0
2019-09-27 3 Maeusli Heinz Christoph PGNX Common Stock, $0.0013 par value D 0
2019-09-27 3 Mims David W. PGNX Common Stock, $0.0013 par value D 0
2019-09-27 3 MacDougall Ann L. PGNX Common Stock, $0.0013 par value D 0
2019-09-11 2019-09-09 4 Velan Capital, L.P. PGNX Common Stock, $0.0013 par value P - Purchase D 4,9947 72.023 360 8.011.733
2019-09-09 2019-09-09 4 LTE Partners, LLC PGNX Common Stock, $0.0013 par value P - Purchase D 4,9393 21.480 106 1.950.000
2019-09-09 2019-09-05 4 LTE Partners, LLC PGNX Common Stock, $0.0013 par value P - Purchase D 4,6208 43.520 201 1.928.520
2019-09-05 2019-09-04 4 Velan Capital, L.P. PGNX Common Stock, $0.0013 par value P - Purchase D 4,5093 243.614 1.099 7.939.710
2019-09-05 2019-09-03 4 Velan Capital, L.P. PGNX Common Stock, $0.0013 par value P - Purchase D 4,3937 277.424 1.219 7.696.096
2019-08-27 3 VENKATARAMAN BALAJI PGNX Common Stock, $0.0013 par value D 14.429.232
2019-08-27 3 VENKATARAMAN BALAJI PGNX Common Stock, $0.0013 par value D 14.429.232
2019-08-27 3 VENKATARAMAN BALAJI PGNX Common Stock, $0.0013 par value D 14.429.232
2019-08-27 3 VENKATARAMAN BALAJI PGNX Common Stock, $0.0013 par value D 14.429.232
2019-08-27 3 VENKATARAMAN BALAJI PGNX Common Stock, $0.0013 par value D 14.429.232
2019-08-27 2019-08-26 4 Velan Capital, L.P. PGNX Common Stock, $0.0013 par value P - Purchase D 4,3003 73.230 315 7.418.672
2019-08-27 2019-08-23 4 Velan Capital, L.P. PGNX Common Stock, $0.0013 par value P - Purchase D 4,3087 130.826 564 7.345.442
2019-08-27 3 Sarpangal Deepak PGNX Common Stock, $0.0013 par value D 0
2019-08-27 3 Melkonian Ryan PGNX Common Stock, $0.0013 par value D 3.770.000
2019-08-27 3 Melkonian Ryan PGNX Common Stock, $0.0013 par value D 3.770.000
2019-08-27 3 Melkonian Ryan PGNX Common Stock, $0.0013 par value D 3.770.000
2019-08-27 3 Melkonian Ryan PGNX Common Stock, $0.0013 par value D 3.770.000
2019-08-27 3 Melkonian Ryan PGNX Common Stock, $0.0013 par value D 3.770.000
2019-08-27 3 Melkonian Ryan PGNX Common Stock, $0.0013 par value D 3.770.000
2019-08-27 3 Nohria Virinder PGNX Common Stock, $0.0013 par value D 220.000
2019-08-27 3 Nohria Virinder PGNX Common Stock, $0.0013 par value D 220.000
2019-08-27 3 Nohria Virinder PGNX Common Stock, $0.0013 par value D 220.000
2019-08-27 3 Cooke Terence PGNX Common Stock, $0.0013 par value D 80.000
2019-08-27 3 Cooke Terence PGNX Common Stock, $0.0013 par value D 80.000
2019-08-27 3 Cooke Terence PGNX Common Stock, $0.0013 par value D 80.000
2019-07-15 2019-07-11 4 KISHBAUCH MICHAEL D PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,74 25.000 25.000
2019-07-15 2019-07-11 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,74 25.000 25.000
2019-07-15 2019-07-11 4 WILLIAMS NICOLE PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,74 25.000 25.000
2019-07-15 2019-07-11 4 Campbell Bradley L PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,74 25.000 25.000
2019-07-15 2019-07-11 4 Crowley Peter J PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,74 55.000 55.000
2019-07-15 2019-07-11 4 Ferrante Karen Jean PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 5,74 25.000 25.000
2019-07-08 2019-07-03 4 Campbell Bradley L PGNX Non-Qualified Stock Option (Right to Buy) M - Exercise D 4,89 -12.000 0
2019-07-08 2019-07-03 4 Campbell Bradley L PGNX Common Stock M - Exercise D 4,8900 12.000 59 12.000
2019-07-03 2019-07-01 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (Right to Buy) M - Exercise D 5,33 -10.000 0
2019-07-03 2019-07-01 4 SCHEINBERG DAVID A PGNX Common Stock M - Exercise D 5,3300 10.000 53 56.185
2019-06-27 2019-06-26 4 Crowley Peter J PGNX Non-Qualified Stock Option (Right to Buy) M - Exercise D 5,33 -10.000 0
2019-06-27 2019-06-26 4 Crowley Peter J PGNX Non-Qualified Stock Option (Right to Buy) M - Exercise D 5,35 -40.000 0
2019-06-27 2019-06-26 4 Crowley Peter J PGNX Common Stock M - Exercise D 5,3500 40.000 214 50.000
2019-06-27 2019-06-26 4 Crowley Peter J PGNX Common Stock M - Exercise D 5,3300 10.000 53 10.000
2019-03-05 2019-03-01 4 Osorio Benedict PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,52 90.750 90.750
2019-03-05 2019-03-01 4 Tenbarge Bryce PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,52 90.750 90.750
2019-03-05 2019-03-01 4 Fabbio Patrick PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,52 90.750 90.750
2019-03-05 2019-03-01 4 Baker Mark Robert PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,52 192.500 192.500
2019-03-05 2019-03-01 4 Wong Vivien PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,52 90.750 90.750
2019-02-05 2019-02-01 4 Das Asha PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,56 125.000 125.000
2019-01-11 3 Das Asha PGNX Common Stock D 0
2018-06-14 2018-06-13 4 Crowley Peter J PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 8,99 55.000 55.000
2018-06-14 2018-06-13 4 KISHBAUCH MICHAEL D PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 8,99 25.000 25.000
2018-06-14 2018-06-13 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 8,99 25.000 25.000
2018-06-14 2018-06-13 4 WILLIAMS NICOLE PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 8,99 25.000 25.000
2018-06-14 2018-06-13 4 Campbell Bradley L PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 8,99 25.000 25.000
2018-06-14 2018-06-13 4 Ferrante Karen Jean PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 8,99 25.000 25.000
2018-03-02 3 Osorio Benedict PGNX Progenics Pharmaceuticals, Inc. Common Stock D 42.404
2018-03-02 3 Osorio Benedict PGNX Progenics Pharmaceuticals, Inc. Common Stock D 42.404
2018-03-02 2018-03-01 4 Osorio Benedict PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,62 100.000 100.000
2018-03-02 2018-03-01 4 Wong Vivien PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,62 94.875 94.875
2018-03-02 2018-03-01 4 Tenbarge Bryce PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,62 75.900 75.900
2018-03-02 2018-03-01 4 Summer Jeffery PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,62 94.875 94.875
2018-03-02 2018-03-01 4 Baker Mark Robert PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,62 201.250 201.250
2018-03-02 2018-03-01 4 Fabbio Patrick PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,62 94.875 94.875
2017-06-15 2017-06-14 4 Campbell Bradley L PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,95 20.000 20.000
2017-06-15 2017-06-14 4 KISHBAUCH MICHAEL D PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,95 20.000 20.000
2017-06-15 2017-06-14 4 WILLIAMS NICOLE PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,95 20.000 20.000
2017-06-15 2017-06-14 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,95 20.000 20.000
2017-06-15 2017-06-14 4 Crowley Peter J PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,95 55.000 55.000
2017-06-15 2017-06-14 4 Ferrante Karen Jean PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,95 20.000 20.000
2017-03-07 2017-03-01 4 Fabbio Patrick PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 11,32 82.500 82.500
2017-03-07 2017-03-01 4 Summer Jeffery PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 11,32 82.500 82.500
2017-03-07 2017-03-01 4 Tenbarge Bryce PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 11,32 66.000 66.000
2017-03-07 2017-03-01 4 Wong Vivien PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 11,32 82.500 82.500
2017-03-07 2017-03-01 4 Baker Mark Robert PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 11,32 175.000 175.000
2017-02-15 2017-02-15 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,5500 -150.000 -1.432 6.997.269
2017-02-15 2017-02-14 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,6800 -150.000 -1.452 7.147.269
2017-02-15 2017-02-14 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,7000 -100.000 -970 7.297.269
2017-02-15 2017-02-14 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,7000 -50.000 -485 7.397.269
2017-02-15 2017-02-14 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,7000 -52.600 -510 7.447.269
2017-02-15 2017-02-13 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,7000 -100.000 -970 7.499.869
2017-02-09 2017-02-09 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,6850 -1.300 -13 7.599.869
2017-02-09 2017-02-09 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,6600 -100.000 -966 7.601.169
2017-02-09 2017-02-09 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,7500 -100.000 -975 7.701.169
2017-02-09 2017-02-07 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,6500 -50.000 -482 7.801.169
2017-02-09 2017-02-07 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock S - Sale D 9,7400 -100.000 -974 7.851.169
2017-01-13 2017-01-11 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock D - Sale to Issuer D 8,9500 -1.000.000 -8.950 7.951.169
2016-10-04 2016-10-03 4 Tenbarge Bryce PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 6,77 75.000 75.000
2016-08-25 3 Tenbarge Bryce PGNX Common Stock D 0
2016-06-09 2016-06-08 4 KISHBAUCH MICHAEL D PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,89 20.000 20.000
2016-06-09 2016-06-08 4 Ferrante Karen Jean PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,89 20.000 20.000
2016-06-09 2016-06-08 4 Crowley Peter J PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,89 55.000 55.000
2016-06-09 2016-06-08 4 Campbell Bradley L PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,89 40.000 40.000
2016-06-09 2016-06-08 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,89 20.000 20.000
2016-06-09 2016-06-08 4 WILLIAMS NICOLE PGNX Non-Qualified Stock Option (Right to Buy) A - Award D 4,89 20.000 20.000
2016-04-22 2010-12-01 4/A MADDON PAUL J PGNX Common Stock P - Purchase D 4,9000 5.000 24 909.891
2016-03-03 2016-03-01 4 Baker Mark Robert PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,52 4,5200 175.000 791 175.000
2016-03-03 2016-03-01 4 Fabbio Patrick PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,52 4,5200 82.500 373 82.500
2016-03-03 2016-03-01 4 Hirt Sheldon PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,52 4,5200 82.500 373 82.500
2016-03-03 2016-03-01 4 Wong Vivien PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,52 4,5200 82.500 373 82.500
2015-12-03 2015-12-01 4 Fabbio Patrick PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,77 6,7700 125.000 846 125.000
2015-08-05 2015-08-03 4 Hirt Sheldon PGNX Non-Qualified Stock Option (right to buy) A - Award D 8,56 8,5600 125.000 1.070 125.000
2015-06-15 2015-06-11 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 6,8300 -2.000 -14 4.000
2015-06-15 2015-06-11 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 6,8300 -2.000 -14 35.050
2015-06-15 2015-06-11 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 2.000 11 37.050
2015-06-11 2015-06-10 4 Crowley Peter J PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,72 6,7200 55.000 370 55.000
2015-06-11 2015-06-10 4 Ferrante Karen Jean PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,72 6,7200 20.000 134 20.000
2015-06-11 2015-06-10 4 KISHBAUCH MICHAEL D PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,72 6,7200 20.000 134 20.000
2015-06-11 2015-06-10 4 MADDON PAUL J PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,72 6,7200 20.000 134 20.000
2015-06-11 2015-06-10 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,72 6,7200 20.000 134 20.000
2015-06-11 2015-06-10 4 WILLIAMS NICOLE PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,72 6,7200 20.000 134 20.000
2015-04-01 3 Wong Vivien PGNX Common Stock D 8.242
2015-04-01 3 Wong Vivien PGNX Common Stock D 8.242
2015-03-16 2015-03-13 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,35 7,0000 -3.000 -21 15.000
2015-03-16 2015-03-13 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 7,0000 -3.000 -21 35.050
2015-03-16 2015-03-13 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3500 3.000 16 38.050
2015-03-13 2015-03-11 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 6,8300 -2.000 -14 6.000
2015-03-13 2015-03-11 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 6,8300 -2.000 -14 35.050
2015-03-13 2015-03-11 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 2.000 11 37.050
2015-03-04 2015-03-03 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 4,70 6,4900 -5.000 -32 61.000
2015-03-04 2015-03-03 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 6,4900 -5.000 -32 35.050
2015-03-04 2015-03-03 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 4,7000 5.000 24 40.050
2015-03-04 2015-03-02 4 KISHBAUCH MICHAEL D PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,65 6,6500 15.342 102 15.342
2015-03-04 2015-03-02 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,65 6,6500 66.000 439 66.000
2015-03-04 2015-03-02 4 Baker Mark Robert PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,65 6,6500 132.000 878 132.000
2015-03-04 2015-03-02 4 Lovallo Angelo William JR PGNX Non-Qualified Stock Option (right to buy) A - Award D 6,65 6,6500 52.800 351 52.800
2015-01-13 2015-01-12 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 7,0560 -2.000 -14 8.000
2015-01-13 2015-01-12 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 7,0560 -2.000 -14 35.050
2015-01-13 2015-01-12 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 2.000 11 37.050
2014-12-12 2014-12-11 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,35 7,0670 -3.000 -21 18.000
2014-12-12 2014-12-11 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 7,0670 -3.000 -21 35.050
2014-12-12 2014-12-11 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3500 3.000 16 38.050
2014-11-21 2014-11-21 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,35 7,0000 -9.000 -63 21.000
2014-11-21 2014-11-21 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 7,0000 -9.000 -63 35.050
2014-11-21 2014-11-21 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3500 9.000 48 44.050
2014-11-14 2014-11-13 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 6,8300 -10.000 -68 10.000
2014-11-14 2014-11-13 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 6,8300 -10.000 -68 35.050
2014-11-14 2014-11-13 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 10.000 53 45.050
2014-11-12 2014-11-11 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,03 6,5300 -5.000 -33 55.000
2014-11-12 2014-11-11 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 6,5300 -5.000 -33 35.050
2014-11-12 2014-11-11 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,0300 5.000 25 40.050
2014-07-23 3 KOTLER KEVIN PGNX Common Stock D 14.651.466
2014-07-23 3 KOTLER KEVIN PGNX Common Stock D 14.651.466
2014-07-23 3 KOTLER KEVIN PGNX Common Stock D 14.651.466
2014-07-23 3 KOTLER KEVIN PGNX Common Stock D 14.651.466
2014-07-23 2014-07-21 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock P - Purchase D 4,7300 388.659 1.838 8.951.169
2014-07-23 2014-07-18 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock P - Purchase D 4,7300 388.200 1.836 8.562.510
2014-07-23 2014-07-17 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock P - Purchase D 4,4800 436.884 1.957 8.174.310
2014-07-23 2014-07-16 4 Broadfin Healthcare Master Fund Ltd PGNX Common Stock P - Purchase D 4,4800 411.693 1.844 7.737.426
2014-06-19 2014-06-17 4 Crowley Peter J PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,47 4,4700 55.000 246 55.000
2014-06-19 2014-06-17 4 KISHBAUCH MICHAEL D PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,47 4,4700 20.000 89 20.000
2014-06-19 2014-06-17 4 MADDON PAUL J PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,47 4,4700 20.000 89 20.000
2014-06-19 2014-06-17 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,47 4,4700 20.000 89 20.000
2014-06-19 2014-06-17 4 WILLIAMS NICOLE PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,47 4,4700 20.000 89 20.000
2014-06-19 2014-06-17 4 Ferrante Karen Jean PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,47 4,4700 20.000 89 20.000
2014-03-04 2014-03-03 4 Baker Mark Robert PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,70 4,7000 132.000 620 132.000
2014-03-04 2014-03-03 4 Youssoufian Hagop PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,70 4,7000 66.000 310 66.000
2014-03-04 2014-03-03 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,70 4,7000 66.000 310 66.000
2014-03-04 2014-03-03 4 Lovallo Angelo William JR PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,70 4,7000 52.800 248 52.800
2014-01-30 2014-01-29 4 Ferrante Karen Jean PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,50 4,5000 40.000 180 40.000
2013-12-19 3/A Lovallo Angelo William JR PGNX Common Stock D 3.389
2013-09-12 2013-09-11 4 KISHBAUCH MICHAEL D PGNX Non-Qualified Stock Option (right to buy) A - Award D 5,91 5,9100 40.000 236 40.000
2013-08-08 2013-08-01 4 Youssoufian Hagop PGNX Non-Qualified Stock Option (right to buy) A - Award D 5,84 5,8400 150.000 876 150.000
2013-07-22 2013-07-18 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 6,3300 -5.000 -32 20.000
2013-07-22 2013-07-18 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 6,3300 -5.000 -32 35.050
2013-07-22 2013-07-18 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 5.000 27 40.050
2013-06-20 2013-06-12 4 Crowley Peter J PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,76 4,7600 55.000 262 55.000
2013-06-20 2013-06-12 4 GOFF STEPHEN P PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,76 4,7600 20.000 95 20.000
2013-06-20 2013-06-12 4 MADDON PAUL J PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,76 4,7600 20.000 95 20.000
2013-06-20 2013-06-12 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,76 4,7600 20.000 95 20.000
2013-06-20 2013-06-12 4 WILLIAMS NICOLE PGNX Non-Qualified Stock Option (right to buy) A - Award D 4,76 4,7600 20.000 95 20.000
2013-04-10 3 Lovallo Angelo William JR PGNX Common Stock D 2.945
2013-04-08 2013-04-04 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) A - Award D 5,03 5,0300 60.000 302 60.000
2013-04-08 2013-04-04 4 Olson William C PGNX Non-Qualified Stock Option (right to buy) A - Award D 5,03 5,0300 60.000 302 60.000
2013-04-08 2013-04-04 4 Baker Mark Robert PGNX Non-Qualified Stock Option (right to buy) A - Award D 5,03 5,0300 120.000 604 120.000
2013-03-28 2013-03-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 5,3600 100 1 161.141
2013-03-28 2013-03-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 5,3400 50 0 161.041
2013-03-28 2013-03-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 5,3100 500 3 160.991
2013-03-22 2013-03-22 4 SCHEINBERG DAVID A PGNX Common Stock M - Exercise D 4,8090 -1.250 -6 46.185
2013-03-22 2013-03-22 4 SCHEINBERG DAVID A PGNX Common Stock M - Exercise D 2,4690 1.250 3 47.435
2013-03-21 2013-03-21 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 2,47 2,4690 1.250 3 1.250
2013-02-28 2013-02-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,7500 227 1 160.491
2013-02-28 2013-02-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,7200 535 1 160.264
2013-02-28 2013-02-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,7100 500 1 159.729
2013-01-23 2013-01-22 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,8300 315 1 159.229
2013-01-23 2013-01-22 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,8200 900 3 158.914
2012-12-26 2012-12-26 4 Baker Mark Robert PGNX Common Stock P - Purchase D 3,0100 1.142 3 158.014
2012-11-30 2012-11-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,1400 7 0 156.872
2012-11-30 2012-11-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,1300 1.000 2 156.865
2012-11-30 2012-11-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,1300 100 0 155.865
2012-11-30 2012-11-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,1260 100 0 155.765
2012-11-30 2012-11-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,1200 100 0 155.665
2012-11-30 2012-11-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,1200 300 1 155.565
2012-11-20 2012-11-19 4 Baker Mark Robert PGNX Common Stock P - Purchase D 1,9580 11.800 23 155.265
2012-11-19 2012-11-16 4 Baker Mark Robert PGNX Common Stock P - Purchase D 1,8220 49.793 91 143.465
2012-11-16 2012-11-15 4 Baker Mark Robert PGNX Common Stock P - Purchase D 1,6860 48.833 82 93.672
2012-10-25 2012-10-24 4 Baker Mark Robert PGNX Common Stock P - Purchase D 2,9550 1.162 3 44.839
2012-09-27 2012-09-26 4 Baker Mark Robert PGNX Common Stock P - Purchase D 3,3200 1.036 3 43.677
2012-08-23 2012-08-22 4 Baker Mark Robert PGNX Common Stock P - Purchase D 4,2340 815 3 42.641
2012-07-26 2012-07-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 10,0370 346 3 41.826
2012-07-03 2012-07-02 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 9,7900 -1.000 -10 25.000
2012-07-03 2012-07-02 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 9,7900 -1.000 -10 35.050
2012-07-03 2012-07-02 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 1.000 5 36.050
2012-06-29 2012-06-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,2900 100 1 41.480
2012-06-29 2012-06-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,2900 179 2 41.380
2012-06-29 2012-06-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,2700 21 0 41.201
2012-06-29 2012-06-27 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,2100 75 1 41.180
2012-06-22 2012-06-20 4 Olson William C PGNX Common Stock D - Sale to Issuer D 8,6870 -1.230 -11 45.544
2012-06-22 2012-06-20 4 ISRAEL ROBERT J PGNX Common Stock D - Sale to Issuer D 8,5820 -3.333 -29 35.050
2012-06-14 2012-06-13 4 Crowley Peter J PGNX Non-Qualified Stock Option (right to buy) A - Award D 7,93 7,9300 40.000 317 40.000
2012-06-14 2012-06-13 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (right to buy) A - Award D 7,93 7,9300 10.000 79 10.000
2012-06-14 2012-06-13 4 WILLIAMS NICOLE PGNX Non-Qualified Stock Option (right to buy) A - Award D 7,93 7,9300 10.000 79 10.000
2012-06-14 2012-06-13 4 GOFF STEPHEN P PGNX Non-Qualified Stock Option (right to buy) A - Award D 7,93 7,9300 10.000 79 10.000
2012-06-14 2012-06-13 4 BRINER KURT W PGNX Non-Qualified Stock Option (right to buy) A - Award D 7,93 7,9300 10.000 79 10.000
2012-06-14 2012-06-13 4 BAKER CHARLES A PGNX Non-Qualified Stock Option (right to buy) A - Award D 7,93 7,9300 10.000 79 10.000
2012-06-14 2012-06-13 4 MADDON PAUL J PGNX Non-Qualified Stock Option (right to buy) A - Award D 7,93 7,9300 10.000 79 10.000
2012-06-04 2012-06-01 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 8,5080 -1.000 -9 26.000
2012-06-04 2012-06-01 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 8,5080 -1.000 -9 38.383
2012-06-04 2012-06-01 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 1.000 5 39.383
2012-05-24 2012-05-23 4 Baker Mark Robert PGNX Common Stock P - Purchase D 7,8100 445 3 41.105
2012-05-03 2012-05-01 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 10,9270 -1.000 -11 27.000
2012-05-03 2012-05-01 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 10,9270 -1.000 -11 38.383
2012-05-03 2012-05-01 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 1.000 5 39.383
2012-04-27 2012-04-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,9200 100 1 40.660
2012-04-27 2012-04-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,9700 100 1 40.560
2012-04-27 2012-04-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 10,2500 15 0 40.460
2012-04-27 2012-04-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 10,2500 133 1 40.445
2012-04-03 2012-04-02 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 9,8520 -1.000 -10 28.000
2012-04-03 2012-04-02 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 9,8520 -1.000 -10 38.383
2012-04-03 2012-04-02 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 1.000 5 39.383
2012-03-29 2012-03-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 10,1900 140 1 40.312
2012-03-29 2012-03-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 10,0000 100 1 40.172
2012-03-29 2012-03-28 4 Baker Mark Robert PGNX Common Stock P - Purchase D 10,1800 103 1 40.072
2012-03-05 2012-03-01 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) A - Award D 9,81 9,8100 50.000 490 50.000
2012-03-05 2012-03-01 4 Olson William C PGNX Non-Qualified Stock Option (right to buy) A - Award D 9,81 9,8100 50.000 490 50.000
2012-03-05 2012-03-01 4 MCKINNEY ROBERT A PGNX Non-Qualified Stock Option (right to buy) A - Award D 9,81 9,8100 50.000 490 50.000
2012-03-05 2012-03-01 4 Baker Mark Robert PGNX Non-Qualified Stock Option (right to buy) A - Award D 9,81 9,8100 33.334 327 100.000
2012-03-05 2012-03-01 4 Baker Mark Robert PGNX Non-Qualified Stock Option (right to buy) A - Award D 9,81 9,8100 66.666 654 66.666
2012-03-02 2012-03-01 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 9,8170 -1.000 -10 29.000
2012-03-02 2012-03-01 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 9,8170 -1.000 -10 38.383
2012-03-02 2012-03-01 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 1.000 5 39.383
2012-02-27 2012-02-23 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 6,90 10,0000 -1.250 -12 0
2012-02-27 2012-02-23 4 SCHEINBERG DAVID A PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 6,90 6,9000 1.250 9 1.250
2012-02-27 2012-02-23 4 SCHEINBERG DAVID A PGNX Common Stock S - Sale D 10,0000 -1.250 -12 46.185
2012-02-27 2012-02-23 4 SCHEINBERG DAVID A PGNX Common Stock M - Exercise D 6,9000 1.250 9 47.435
2012-02-23 2012-02-22 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,5400 1 0 39.969
2012-02-23 2012-02-22 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,4500 100 1 39.968
2012-02-23 2012-02-22 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,4200 2 0 39.868
2012-02-23 2012-02-22 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,4000 100 1 39.866
2012-02-23 2012-02-22 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,4000 166 2 39.766
2012-02-03 2012-02-03 4 BRINER KURT W PGNX Common Stock S - Sale D 10,2190 -33.000 -337 0
2012-02-02 2012-02-01 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 9,4780 -1.000 -9 30.000
2012-02-02 2012-02-01 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 9,4780 -1.000 -9 38.383
2012-02-02 2012-02-01 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 1.000 5 39.383
2012-01-26 2012-01-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,5600 100 1 39.600
2012-01-26 2012-01-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,5500 193 2 39.500
2012-01-26 2012-01-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,5000 4 0 39.307
2012-01-26 2012-01-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,4900 3 0 39.303
2012-01-26 2012-01-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,4500 1 0 39.300
2012-01-26 2012-01-25 4 Baker Mark Robert PGNX Common Stock P - Purchase D 9,4500 63 1 39.299
2012-01-12 2012-01-11 4 Baker Mark Robert PGNX Common Stock P - Purchase D 8,8700 200 2 39.236
2012-01-12 2012-01-11 4 Baker Mark Robert PGNX Common Stock P - Purchase D 8,8600 191 2 39.036
2012-01-12 2011-10-26 4 Baker Mark Robert PGNX Common Stock P - Purchase D 6,5000 76 0 38.211
2012-01-12 2011-10-26 4 Baker Mark Robert PGNX Common Stock P - Purchase D 6,5200 455 3 38.135
2012-01-12 2011-10-26 4 Baker Mark Robert PGNX Common Stock P - Purchase D 6,5300 1 0 37.680
2012-01-04 2012-01-03 4 ISRAEL ROBERT J PGNX Non-Qualified Stock Option (right to buy) M - Exercise D 5,33 8,7800 -1.000 -9 31.000
2012-01-04 2012-01-03 4 ISRAEL ROBERT J PGNX Common Stock S - Sale D 8,7800 -1.000 -9 38.383
2012-01-04 2012-01-03 4 ISRAEL ROBERT J PGNX Common Stock M - Exercise D 5,3300 1.000 5 39.383
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista